(QCOM) Qualcomm - Overview
Stock: Chipsets, Modems, Licensing
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.21% |
| Yield on Cost 5y | 3.33% |
| Yield CAGR 5y | 6.95% |
| Payout Consistency | 82.4% |
| Payout Ratio | 29.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 48.8% |
| Relative Tail Risk | -5.08% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.38 |
| Alpha | -41.43 |
| Character TTM | |
|---|---|
| Beta | 1.488 |
| Beta Downside | 1.630 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.23% |
| CAGR/Max DD | 0.10 |
Description: QCOM Qualcomm January 26, 2026
Qualcomm Incorporated (NASDAQ: QCOM) develops and commercializes core wireless technologies through three operating segments: Qualcomm CDMA Technologies (QCT), which designs integrated circuits and system software for mobile phones, automotive connectivity, and IoT; Qualcomm Technology Licensing (QTL), which monetizes a portfolio of standard-essential patents covering 3G, 4G, and 5G; and Qualcomm Strategic Initiatives (QSI), which invests in early-stage companies and provides specialized services to U.S. government customers.
In its most recent quarter (Q4 2023), Qualcomm reported revenue of $13.5 billion, a 12 % year-over-year increase driven primarily by a 20 % rise in 5G handset shipments and a 15 % growth in automotive-related chip sales. The company’s gross margin expanded to 55 % and R&D expenditure reached $5.3 billion, reflecting continued investment in next-generation RF and AI-enabled silicon.
Key macro drivers include the accelerating global rollout of 5G networks (over 3.5 billion connections projected by 2027), rising demand for connected-car features such as ADAS and digital cockpits, and expanding IoT deployments in industrial automation. For a deeper, data-rich analysis of how these trends translate into valuation metrics, consider exploring ValueRay’s research platform.
Piotroski VR‑10 (Strict, 0-10) 9.5
| Net Income: 5.37b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA 1.46 > 1.0 |
| NWC/Revenue: 32.96% < 20% (prev 39.59%; Δ -6.63% < -1%) |
| CFO/TA 0.27 > 3% & CFO 14.39b > Net Income 5.37b |
| Net Debt (7.61b) to EBITDA (13.73b): 0.55 < 3 |
| Current Ratio: 2.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.08b) vs 12m ago -3.83% < -2% |
| Gross Margin: 55.10% > 18% (prev 0.56%; Δ 5454 % > 0.5%) |
| Asset Turnover: 82.62% > 50% (prev 73.23%; Δ 9.40% > 0%) |
| Interest Coverage Ratio: 13.74 > 6 (EBITDA TTM 13.73b / Interest Expense TTM 670.0m) |
Altman Z'' 5.16
| A: 0.28 (Total Current Assets 24.61b - Total Current Liabilities 9.82b) / Total Assets 53.03b |
| B: 0.42 (Retained Earnings 22.50b / Total Assets 53.03b) |
| C: 0.17 (EBIT TTM 9.20b / Avg Total Assets 54.30b) |
| D: 0.77 (Book Value of Equity 23.07b / Total Liabilities 29.96b) |
| Altman-Z'' Score: 5.16 = AAA |
Beneish M -3.07
| DSRI: 1.06 (Receivables 4.15b/3.55b, Revenue 44.87b/40.70b) |
| GMI: 1.02 (GM 55.10% / 55.99%) |
| AQI: 0.98 (AQ_t 0.44 / AQ_t-1 0.45) |
| SGI: 1.10 (Revenue 44.87b / 40.70b) |
| TATA: -0.17 (NI 5.37b - CFO 14.39b) / TA 53.03b) |
| Beneish M-Score: -3.07 (Cap -4..+1) = AA |
What is the price of QCOM shares?
Over the past week, the price has changed by -9.40%, over one month by -24.72%, over three months by -20.30% and over the past year by -17.07%.
Is QCOM a buy, sell or hold?
- StrongBuy: 12
- Buy: 5
- Hold: 19
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the QCOM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 166 | 20.9% |
| Analysts Target Price | 166 | 20.9% |
| ValueRay Target Price | 130.1 | -5.2% |
QCOM Fundamental Data Overview February 07, 2026
P/E Forward = 11.2486
P/S = 3.2693
P/B = 6.3031
P/EG = 0.459
Revenue TTM = 44.87b USD
EBIT TTM = 9.20b USD
EBITDA TTM = 13.73b USD
Long Term Debt = 14.82b USD (from longTermDebt, last quarter)
Short Term Debt = 102.0m USD (from shortTermDebt, last fiscal year)
Debt = 14.82b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.61b USD (from netDebt column, last quarter)
Enterprise Value = 149.68b USD (146.69b + Debt 14.82b - CCE 11.82b)
Interest Coverage Ratio = 13.74 (Ebit TTM 9.20b / Interest Expense TTM 670.0m)
EV/FCF = 11.58x (Enterprise Value 149.68b / FCF TTM 12.93b)
FCF Yield = 8.64% (FCF TTM 12.93b / Enterprise Value 149.68b)
FCF Margin = 28.81% (FCF TTM 12.93b / Revenue TTM 44.87b)
Net Margin = 11.96% (Net Income TTM 5.37b / Revenue TTM 44.87b)
Gross Margin = 55.10% ((Revenue TTM 44.87b - Cost of Revenue TTM 20.14b) / Revenue TTM)
Gross Margin QoQ = 54.55% (prev 55.34%)
Tobins Q-Ratio = 2.82 (Enterprise Value 149.68b / Total Assets 53.03b)
Interest Expense / Debt = 1.14% (Interest Expense 169.0m / Debt 14.82b)
Taxrate = 15.31% (543.0m / 3.55b)
NOPAT = 7.79b (EBIT 9.20b * (1 - 15.31%))
Current Ratio = 2.51 (Total Current Assets 24.61b / Total Current Liabilities 9.82b)
Debt / Equity = 0.64 (Debt 14.82b / totalStockholderEquity, last quarter 23.07b)
Debt / EBITDA = 0.55 (Net Debt 7.61b / EBITDA 13.73b)
Debt / FCF = 0.59 (Net Debt 7.61b / FCF TTM 12.93b)
Total Stockholder Equity = 24.80b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.88% (Net Income 5.37b / Total Assets 53.03b)
RoE = 21.63% (Net Income TTM 5.37b / Total Stockholder Equity 24.80b)
RoCE = 23.23% (EBIT 9.20b / Capital Employed (Equity 24.80b + L.T.Debt 14.82b))
RoIC = 19.70% (NOPAT 7.79b / Invested Capital 39.56b)
WACC = 10.44% (E(146.69b)/V(161.50b) * Re(11.40%) + D(14.82b)/V(161.50b) * Rd(1.14%) * (1-Tc(0.15)))
Discount Rate = 11.40% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.15%
[DCF Debug] Terminal Value 71.71% ; FCFF base≈12.85b ; Y1≈14.41b ; Y5≈19.19b
Fair Price DCF = 201.1 (EV 222.17b - Net Debt 7.61b = Equity 214.56b / Shares 1.07b; r=10.44% [WACC]; 5y FCF grow 14.09% → 2.90% )
EPS Correlation: 26.91 | EPS CAGR: 2.33% | SUE: 0.68 | # QB: 0
Revenue Correlation: 30.53 | Revenue CAGR: 2.51% | SUE: 0.26 | # QB: 0
EPS next Quarter (2026-03-31): EPS=2.66 | Chg30d=-0.234 | Revisions Net=-6 | Analysts=26
EPS current Year (2026-09-30): EPS=11.29 | Chg30d=-0.812 | Revisions Net=-6 | Growth EPS=-6.2% | Growth Revenue=-0.5%
EPS next Year (2027-09-30): EPS=11.53 | Chg30d=-0.896 | Revisions Net=-7 | Growth EPS=+2.1% | Growth Revenue=+1.2%